Fetuses respond differently to COVID-19 based on sex, study finds

A study published Oct. 19 in Science Translational Medicine found male placentas showed increased immune activation compared with female placentas in pregnant women who tested positive for COVID-19.

Advertisement

The study included 68 pregnant women, 38 of whom became infected with COVID-19 during their third trimester prior to the development of the vaccine. The remaining 30 subjects were healthy pregnant women who tested negative for COVID-19. Half the fetuses were male and half were female in both groups.

Key takeaways: 

  • The placentas of male fetuses carried by women with COVID-19 had much higher expression of interferon-stimulated genes.
  • Mothers with COVID-19 carrying male fetuses make lower levels of antibodies against the virus than those carrying female fetuses.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.